14.66
前日終値:
$14.30
開ける:
$14.31
24時間の取引高:
393.27K
Relative Volume:
0.99
時価総額:
$738.30M
収益:
$62.02M
当期純損益:
$-45.65M
株価収益率:
-15.93
EPS:
-0.92
ネットキャッシュフロー:
$-9.60M
1週間 パフォーマンス:
+2.66%
1か月 パフォーマンス:
+0.41%
6か月 パフォーマンス:
+50.05%
1年 パフォーマンス:
+77.91%
Theravance Biopharma Inc Stock (TBPH) Company Profile
名前
Theravance Biopharma Inc
セクター
電話
650-808-6000
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma Inc
|
14.66 | 720.17M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-12 | 開始されました | B. Riley Securities | Buy |
| 2024-08-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 開始されました | BTIG Research | Buy |
| 2024-01-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2021-11-05 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-15 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2021-08-25 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 開始されました | JP Morgan | Overweight |
| 2020-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 開始されました | Cowen | Outperform |
| 2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-06 | アップグレード | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-29 | 再開されました | Piper Jaffray | Overweight |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-06-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-12-21 | 開始されました | Needham | Buy |
| 2016-11-03 | 開始されました | Piper Jaffray | Overweight |
| 2016-10-12 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 開始されました | Guggenheim | Buy |
| 2016-06-20 | 繰り返されました | Leerink Partners | Outperform |
| 2016-05-12 | 開始されました | Leerink Partners | Outperform |
| 2016-05-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | アップグレード | Robert W. Baird | Underperform → Neutral |
すべてを表示
Theravance Biopharma Inc (TBPH) 最新ニュース
Can Theravance Biopharma Inc. stock deliver consistent earnings growthJuly 2025 Momentum & AI Powered Market Trend Analysis - newser.com
Can Theravance Biopharma Inc. stock attract ESG capital inflowsPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Will a bounce in Theravance Biopharma Inc. offer an exitQuarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
What to expect from Theravance Biopharma Inc. in the next 30 daysIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
How to escape a deep drawdown in Theravance Biopharma Inc.2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Can Theravance Biopharma Inc. (0TB) stock sustain revenue momentumMarket Risk Report & Reliable Entry Point Trade Alerts - newser.com
Why Theravance Biopharma Inc. (0TB) stock remains stableJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Theravance Biopharma Inc. stock see insider buyingIPO Watch & Weekly High Return Stock Opportunities - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targetsIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Is Theravance Biopharma Inc. (0TB) stock a momentum leaderPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy? - sharewise.com
What consensus target says about Theravance Biopharma Inc. (0TB) stockPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionWeekly Loss Report & Weekly High Return Forecasts - newser.com
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System - Lelezard
Theravance Biopharma Inc. stock trendline breakdown2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Can Theravance Biopharma Inc. stock maintain operating marginsMarket Risk Analysis & Verified High Yield Trade Plans - newser.com
Why Theravance Biopharma Inc. stock is in analyst buy zoneStop Loss & Momentum Based Trading Signals - newser.com
What indicators show strength in Theravance Biopharma Inc.Market Growth Review & Verified Technical Trade Signals - newser.com
Theravance Biopharma Inc. stock retracement – recovery analysisJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Theravance Biopharma, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025 - Lelezard
Theravance Biopharma (NASDAQ: TBPH) schedules Nov 10 results call at 5 pm EST - Stock Titan
Theravance Biopharma Inc (TBPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):